Sign up to watch this video
Free access to all Sound Bites content
Dr. Tara Graff reviews the efficacy of Pola-R-CHP in select LBCL subgroups (Video 2/3)
Published Apr 20, 2026
Medical Professional
POLARIX subgroups
Related Videos
Dr. Eytan Stein discusses durability of treatment in IC-ineligible AML (Video 1/3)
Eytan Stein, MD
Dr. Ghaith Abu-Zeinah discusses when to initiate treatment in essential thrombocythemia (Video 3/3)
Ghaith Abu-Zeinah, MD
Dr. Sandip Patel describes re-challenging with chemotherapy in patients who received 1L osimertinib + chemotherapy. (Video 3/3)
Sandip Patel, MD
Dr. Joshua Richter highlights the patient types that may benefit most from mezigdomide (Video 3/3)
Joshua Richter, MD
Dr. Joe Mendez reviews the watch and wait vorasidenib patient profile in low-grade gliomas (Video 3/3)
Joe Mendez, MD
Dr. Ghaith Abu-Zeinah reviews the risks and threats in essential thrombocythemia (Video 2/3)
Ghaith Abu-Zeinah, MD
IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America
© 2026 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.